2023-05-03 17:01:19 ET
- Inari Medical press release ( NASDAQ: NARI ): Q1 GAAP EPS of -$0.04 beats by $0.19 .
- Revenue of $116.2M (+33.9% Y/Y) beats by $5.9M .
- Ended the quarter with $328.4 million in cash, cash equivalents and short-term investments.
- Outlook: For the full year 2023, we are revising our revenue guidance to a range of $478 million to $488 million vs. consensus of $476.12M, an increase of $8.0 million from our original guidance range of $470 million to $480 million.
For further details see:
Inari Medical beats Q1 top and bottom line estimates; raises FY23 outlook